 |
Diabetes Mellitus, Type 2 - Drug therapy
Research News and Information
Definition of 'Diabetes Mellitus, Type 2'A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Common names: Diabetes Mellitus, Type 2; Diabetes Mellitus, Ketosis-Resistant; Diabetes Mellitus, Ketosis Resistant; Ketosis-Resistant Diabetes Mellitus; Diabetes Mellitus, Maturity-Onset; Diabetes Mellitus, Maturity Onset; Diabetes Mellitus, Non Insulin Dependent; Diabetes Mellitus, Non-Insulin-Dependent |
Monday, November 23, 2009
30 Oct 2009 
PURPOSE: To study glycemic control and hypoglycemia development upon initiation of insulin through a self-titration schedule in a 24-week trial, conducted with 4875 insulin-naïve patients with poorly controlled type 2 diabetes, predominantly in a ... Read more...
Three-year efficacy of complex insulin regimens in type 2 diabetes.
20 Oct 2009 BACKGROUND: Evidence supporting the addition of specific insulin regimens to oral therapy in patients with type 2 diabetes mellitus is limited. METHODS: In this 3-year open-label, multicenter trial, we evaluated 708 patients who had suboptimal ... Read more...
6 Oct 2009 Type 2 diabetes is a polygenic disease which afflicts nearly 200 million people worldwide and is expected to increase to near epidemic levels over the next 10-15 years. Glucokinase (GK) activators are currently under investigation by a number of ... Read more...
Latest indexed articles for 'Diabetes Mellitus, Type 2 - Drug therapy'
These are the very latest articles for this heading:
- A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). 30 Oct 2009
- Three-year efficacy of complex insulin regimens in type 2 diabetes. 20 Oct 2009
- Optimal insulin treatment in type 2 diabetes.
20 Oct 2009 - Variation in event rates in trials of patients with type 2 diabetes. 19 Oct 2009
- Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes. 6 Oct 2009
- Adverse events in diabetes drug trial. Oct 2009
- Pharmacotherapy of hyperglycemia. 29 Sep 2009
- Dapagliflozin: where does it fit in the treatment of type 2 diabetes? 29 Sep 2009
- Metformin: diamonds are forever. 29 Sep 2009
- Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes. 29 Sep 2009
- Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. 29 Sep 2009
- Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009
- Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009
- Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009
- Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine. 29 Sep 2009
- Rosiglitazone and pioglitazone. Beware fractures. 27 Sep 2009
- The diabetes mellitus medication choice decision aid: a randomized trial. 26 Sep 2009
- Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria. 15 Sep 2009
- Metformin associated lactic acidosis. 14 Sep 2009
- Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. 14 Sep 2009
See a longer list of these articles.
Technical information about 'Diabetes Mellitus, Type 2'
Definition: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Descriptor UI: D003924
Alternative terms: Diabetes Mellitus, Type 2; Diabetes Mellitus, Ketosis-Resistant; Diabetes Mellitus, Ketosis Resistant; Ketosis-Resistant Diabetes Mellitus; Diabetes Mellitus, Maturity-Onset; Diabetes Mellitus, Maturity Onset; Diabetes Mellitus, Non Insulin Dependent; Diabetes Mellitus, Non-Insulin-Dependent; Non-Insulin-Dependent Diabetes Mellitus; Type 2 Diabetes Mellitus; Diabetes Mellitus, Slow-Onset; Diabetes Mellitus, Slow Onset; Slow-Onset Diabetes Mellitus; Diabetes Mellitus, Stable; Stable Diabetes Mellitus; Diabetes Mellitus, Type II; Maturity-Onset Diabetes Mellitus; Maturity Onset Diabetes Mellitus; MODY; NIDDM; Diabetes Mellitus, Adult-Onset; Adult-Onset Diabetes Mellitus; Diabetes Mellitus, Adult Onset; Diabetes Mellitus, Noninsulin Dependent;
Related Mesh Headings: Rats, Inbred OLETF; Metabolic Syndrome X;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;
Tree Number: C18.452.394.750.149; C19.246.300;
History Note: 2005 (1984)